David R, Brenin, MD
Biomarkers for breast cancer detection and progression
Dr. Brenin's research program includes studies of nipple aspirate and ductal lavage fluid obtained from patients with breast cancer. Proteomic analysis will be preformed in order to identify new bio-markers that may be useful for early detection and determination of prognosis. This study makes use of the cancer centers tissue procurement facility as well as statistical analysis preformed by cancer center statisticians.
Other studies related to breast cancer utilize the prospective data repository that collects extensive information on patient demographics, patient personal and family history, tumor characteristics, breast imaging, pathology, multidisciplinary treatments, and follow-up statistics for its cancer patients. The breadth of information gathered in this database far exceeds that of cancer registries or of administrative databases typically utilized to perform health services or epidemiological studies.